Related references
Note: Only part of the references are listed.Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer
Shannon N. Westin et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)
Impact of socio-economic deprivation on endometrial cancer survival in the North West of England: a prospective database analysis
K. Njoku et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2021)
The diagnostic value of human epididymis protein 4 for endometrial cancer is moderate
Jing Liu et al.
SCIENTIFIC REPORTS (2021)
Prognostic value of serum HE4 level in the management of endometrial cancer: A pilot study
Niveditha Rajadevan et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2021)
HE4 and CA125 as preoperative risk strati fi ers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status
Sharon A. O'Toole et al.
GYNECOLOGIC ONCOLOGY (2021)
Diagnostic accuracy of cytology for the detection of endometrial cancer in urine and vaginal samples
Helena O'Flynn et al.
NATURE COMMUNICATIONS (2021)
Endometrial cancer: A systematic review of HE4, REM and REM-B
Manon Degez et al.
CLINICA CHIMICA ACTA (2021)
Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
Aneta Cymbaluk-Ploska et al.
DIAGNOSTICS (2021)
Association of preoperative serum HE4 levels on the survival of patients with endometrial cancer
Putsarat Insin et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2021)
Weight Loss During Intrauterine Progestin Treatment for Obesity-associated Atypical Hyperplasia and Early-Stage Cancer of The Endometrium
Chloe E. Barr et al.
CANCER PREVENTION RESEARCH (2021)
Estimated Performance of Transvaginal Ultrasonography for Evaluation of Postmenopausal Bleeding in a Simulated Cohort of Black and White Women in the US
Kemi M. Doll et al.
JAMA ONCOLOGY (2021)
The Clinical Significance of DJ1 and L1CAM Serum Level Monitoring in Patients with Endometrial Cancer
Marketa Bednarikova et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Comprehensive Library Generation for Identification and Quantification of Endometrial Cancer Protein Biomarkers in Cervico-Vaginal Fluid
Kelechi Njoku et al.
CANCERS (2021)
HE4 in the Diagnostic Approach of Endometrial Cancer in Patients with Postmenopausal Bleeding, the METRODEC Protocol: Protocol for a Multicenter Prospective Study
Manon Degez et al.
DIAGNOSTICS (2021)
Comparison of two immunoassays for the measurement of serum HE4 for ovarian cancer
Chloe E. Barr et al.
PRACTICAL LABORATORY MEDICINE (2021)
Efficacy of the LNG-IUS for treatment of endometrial hyperplasia and early stage endometrial cancer: Can biomarkers predict response?
Molly Dore et al.
GYNECOLOGIC ONCOLOGY REPORTS (2021)
Detecting endometrial cancer
Eleanor R. Jones et al.
OBSTETRICIAN & GYNAECOLOGIST (2021)
Lynch syndrome for the gynaecologist
Neil A. J. Ryan et al.
OBSTETRICIAN & GYNAECOLOGIST (2021)
Value of preoperative neutrophil-lymphocyte ratio and human epididymis protein 4 in predicting lymph node metastasis in endometrial cancer patients
Min Gao et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2021)
Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer
Roya Behrouzi et al.
CANCERS (2020)
Mirena coil is a suitable treatment of early-stage endometrial cancer in obese women FOR: Careful selection and monitoring is key
Chloe E. Barr et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2020)
HE4 tumor marker as a predictive factor for lymphatic metastasis in endometrial cancer
Andrea Espiau Romera et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2020)
Age and menopausal status are important factors influencing the serum human epididymis secretory protein 4 level: a prospective cross-sectional study in healthy Chinese people
Hong-Yan Cheng et al.
CHINESE MEDICAL JOURNAL (2020)
Authors' reply re: Mirena Coil is a suitable treatment of early-stage endometrial cancer in obese women: FOR or AGAINST? Treat the patient, not the disease
Chloe E. Barr et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2020)
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
Alicia Leon-Castillo et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Meta-analysis of the diagnostic accuracy of HE4 for endometrial carcinoma
Jing Liu et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2020)
Diagnostic and Prognostic Values of Serum EpCAM, TGM2, and HE4 Levels in Endometrial Cancer
Ting Lan et al.
FRONTIERS IN ONCOLOGY (2020)
Preoperative markers for the prediction of high-risk features in endometrial cancer
Pinyada Panyavaranant et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2020)
A New Risk Index Combining d-Dimer, Fibrinogen, HE4, and CA199 Differentiates Suspecting Endometrial Cancer From Patients With Abnormal Vaginal Bleeding or Discharge
Lili Ge et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
The Utility of CA125 and HE4 in Patients Suffering From Endometrial Cancer
Narges Zamani et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH AND REPRODUCTION SCIENCES (2020)
Effectiveness of progestin-based therapy for morbidly obese women with complex atypical hyperplasia
Marcia A. Ciccone et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2019)
Sentinel node mapping vs. lymphadenectomy in endometrial cancer: A systematic review and meta-analysis
Giorgio Bogani et al.
GYNECOLOGIC ONCOLOGY (2019)
Top ten research priorities for detecting cancer early
Ellena Badrick et al.
LANCET PUBLIC HEALTH (2019)
Comparison of serum human epididymis protein 4 and CA125 on endometrial cancer detection: A meta-analysis
Jinping Li et al.
CLINICA CHIMICA ACTA (2019)
Endometrial cancer and obesity
Sarah J. Kitson et al.
OBSTETRICIAN & GYNAECOLOGIST (2019)
The clinical significance of DJ-1 and HE4 in patients with endometrial cancer
Marco Benati et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2018)
Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device
Navdeep Pal et al.
OBSTETRICS AND GYNECOLOGY (2018)
Patient-initiated follow up affects fear of recurrence and healthcare use: a randomised trial in early-stage endometrial cancer
M. M. Jeppesen et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2018)
Human epididymis protein 4 in endometrial cancer: A meta-analysis
Li-man Li et al.
CLINICA CHIMICA ACTA (2018)
Implementing the Risk of Endometrial Malignancy Algorithm (REM) adding obesity as a predictive factor: Results of REM-B in a single-center survey
Francesco Plotti et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2018)
HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients
Karin Abbink et al.
TUMOR BIOLOGY (2018)
Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women A Systematic Review and Meta-analysis
Megan A. Clarke et al.
JAMA INTERNAL MEDICINE (2018)
Role of imaging in the routine management of endometrial cancer
Ming Yin Lin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
Prognostic values of HE4 expression in patients with cancer: a meta-analysis
Cong Dai et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Conservative management of endometrial hyperplasia or carcinoma with the levonorgestrel intrauterine system may be less effective in morbidly obese patients
Ashley Graul et al.
GYNECOLOGIC ONCOLOGY REPORTS (2018)
Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer
Yingmei Wang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2017)
The role of human epididymis secretory protein E4 in patients with endometrial cancer and premalignant endometrial lesions
Setenay Arzu Yilmaz et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2017)
Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer
Jing Bian et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2017)
BGCS uterine cancer guidelines: Recommendations for practice
Sudha Sundar et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2017)
Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer
Tamara Knific et al.
GYNECOLOGIC ONCOLOGY (2017)
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset
Francesco Plotti et al.
MEDICAL ONCOLOGY (2017)
Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer
A. Stiekema et al.
VIRCHOWS ARCHIV (2017)
Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer
Josef Chovanec et al.
ONCOTARGET (2017)
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients
Marika Vezzoli et al.
SCIENTIFIC REPORTS (2017)
Lymphadenectomy for the management of endometrial cancer
J. A. Frost et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Diagnostic Performance of Serum Human Epididymis Protein 4 in Endometrial Carcinoma: A Pilot Study
Rupali Dewan et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2017)
Value of HE4 combined with cancer Antigen 125 in the diagnosis of Endometrial Cancer
Chunhua Dong et al.
PAKISTAN JOURNAL OF MEDICAL SCIENCES (2017)
Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis
Anna Jo Bodurtha Smith et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management
Jiri Presl et al.
ANTICANCER RESEARCH (2017)
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
N. Colombo et al.
ANNALS OF ONCOLOGY (2016)
Recombinant HE4 protein promotes proliferation of pancreatic and endometrial cancer cell lines
Qinsheng Lu et al.
ONCOLOGY REPORTS (2016)
The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program
Roberto Angioli et al.
TUMOR BIOLOGY (2016)
Utility of HE4 to identify patients with endometrioid endometrial cancer who may require lymphadenectomy
Bozena Dobrzycka et al.
ADVANCES IN MEDICAL SCIENCES (2016)
Preoperative local staging of endometrial cancer: the challenge of imaging techniques and serum biomarkers
Roberto Angioli et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
Association of Serum HE4 with Primary Tumor Diameter and Depth of Myometrial Invasion in Endometrial Cancer Patients at Rajavithi Hospital
Nisa Prueksaritanond et al.
Asian Pacific Journal of Cancer Prevention (2016)
HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
Anne Orbo et al.
BRITISH JOURNAL OF CANCER (2016)
Value of serum human epididymis secretory protein 4 as a marker for differential diagnosis of malignant and benign gynecological diseases of patients in southern China
Laisheng Li et al.
CLINICA CHIMICA ACTA (2016)
Verification of the harmonization of human epididymis protein 4 assays
Simona Ferraro et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis
Nehalennia van Hanegem et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2016)
Physiopathological factors affecting the diagnostic value of serum HE4-test for gynecologic malignancies
Wanglei Qu et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
HE4 differentiating benign and malignant endometrial pathology
Emilia Gąsiorowska et al.
Ginekologia Polska (2016)
The role of HE4 and CA125 in differentiation between malignant and non-malignant endometrial pathologies
Nabil Abdalla et al.
GINEKOLOGIA POLSKA (2016)
Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer
Pinar Kemik et al.
GYNECOLOGIC ONCOLOGY (2016)
Working together to shape the endometrial cancer research agenda: The top ten unanswered research questions
Y. Louise Wan et al.
GYNECOLOGIC ONCOLOGY (2016)
Endometrial Cancer and the Role of Lymphadenectomy
Leslie H. Clark et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2016)
Analysis of serum level of HE4 and CA125 considering selected risk factors among patients with endometrioid endometrial cancer
Nabil Abdalla et al.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY (2016)
Diagnostic Value of Novel Biomarker Human Epididymis Protein 4 (HE4) in Detecting Endometrial Cancer
Mehri Jafari-Shobeiri et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH AND REPRODUCTION SCIENCES (2016)
Endometrial and Ovarian Cancer with MR Imaging Importance of Serum HE4 and CA 125 Levels in the Extent of Disease at Evaluation
Emsal Pinar Topdagi Yilmaz et al.
EURASIAN JOURNAL OF MEDICINE (2016)
Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance
Donal J. Brennan et al.
BMC CANCER (2015)
Human epididymis protein 4 (HE4) in laboratory medicine and an algorithm in renal disorders
Janos Kappelmayer et al.
CLINICA CHIMICA ACTA (2015)
Prognostic value of human epididymis protein 4 in endometrial cancer and its utility for surgical staging
Lubos Minar et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2015)
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
Ellen Stelloo et al.
MODERN PATHOLOGY (2015)
Progestins in the Fertility-Sparing Treatment and Retreatment of Patients With Primary and Recurrent Endometrial Cancer
Jeong-Yeol Park et al.
ONCOLOGIST (2015)
Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study
Stella Capriglione et al.
TUMOR BIOLOGY (2015)
Determination of reference intervals of serum levels of human epididymis protein 4 (HE4) in Chinese women
Yaping Tian et al.
JOURNAL OF OVARIAN RESEARCH (2015)
Which imaging technique should we use in the follow up of gynaecological cancer?
Antonia Carla Testa et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2014)
Serum HE4 as a prognostic marker in endometrial cancer - A population based study
Donal. J. Brennan et al.
GYNECOLOGIC ONCOLOGY (2014)
Human Epididymis Protein 4 and Secretory Leukocyte Protease Inhibitor in Vaginal Fluid Relation to Vaginal Components and Bacterial Composition
Theofano Orfanelli et al.
REPRODUCTIVE SCIENCES (2014)
HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)
Sofie L. Antonsen et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2013)
REM (Risk of Endometrial Malignancy): A Proposal for a New Scoring System to Evaluate Risk of Endometrial Malignancy
Roberto Angioli et al.
CLINICAL CANCER RESEARCH (2013)
HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines
Jinping Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
The role of novel biomarker HE4 in endometrial cancer: a case control prospective study
Roberto Angioli et al.
TUMOR BIOLOGY (2013)
The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients
Beyhan Omer et al.
TUMOR BIOLOGY (2013)
Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age
Richard G. Moore et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome
Laura Zanotti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2012)
Human epididymis protein 4 (HE4) in benign and malignant diseases
Linda Hertlein et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2012)
Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer
Eleftheria Kalogera et al.
GYNECOLOGIC ONCOLOGY (2012)
HE4 is an independent prognostic marker in endometrial cancer patients
Irene Mutz-Dehbalaie et al.
GYNECOLOGIC ONCOLOGY (2012)
Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: A meta-analysis and systematic review of the literature
J. Baker et al.
GYNECOLOGIC ONCOLOGY (2012)
Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic review
Camille C. Gunderson et al.
GYNECOLOGIC ONCOLOGY (2012)
Human epididymis protein 4 reference limits and natural variation in a Nordic reference population
Nils Bolstad et al.
TUMOR BIOLOGY (2012)
Elevated human epididymis protein 4 concentrations in chronic kidney disease
Bela Nagy et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2012)
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
E. Bignotti et al.
BRITISH JOURNAL OF CANCER (2011)
Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases
Yongjung Park et al.
CLINICAL BIOCHEMISTRY (2011)
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases
Jose M. Escudero et al.
CLINICAL CHEMISTRY (2011)
Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia
Zeina J. Haoula et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2011)
Receiver Operating Characteristic Curve in Diagnostic Test Assessment
Jayawant N. Mandrekar
JOURNAL OF THORACIC ONCOLOGY (2010)
Pain relief for outpatient hysteroscopy
Gaity Ahmad et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Is Complete Surgical Staging Necessary in Clinically Early-Stage Endometrial Carcinoma?
Nakarin Sirisabya et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Should Preoperative Pathology Be Used to Select Patients for Surgical Staging in Endometrial Cancer?
Julie A. Francis et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Role of magnetic resonance imaging and cause of pitfalls in detecting myometrial invasion and cervical involvement in endometrial cancer
A. Sanjuan et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2008)
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
Richard G. Moore et al.
GYNECOLOGIC ONCOLOGY (2008)
Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus
Richard G. Moore et al.
GYNECOLOGIC ONCOLOGY (2008)
Efficacy of routine follow-up in patients with recurrent uterine cancer
Christopher J. Smith et al.
GYNECOLOGIC ONCOLOGY (2007)
Comprehensive analysis of HE4 expression in normal and malignant human tissues
Mary T. Galgano et al.
MODERN PATHOLOGY (2006)
Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia - A Gynecologic Oncology Group Study
CL Trimble et al.
CANCER (2006)
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
EE Calle et al.
NATURE REVIEWS CANCER (2004)
Survival after relapse in patients with endometrial cancer:: results from a randomized trial
CL Creutzberg et al.
GYNECOLOGIC ONCOLOGY (2003)
Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia - A systematic quantitative review
TJ Clark et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
